BSE Live
Apr 06, 16:01Prev. Close
4881.95
Open Price
4859.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 06, 15:44Prev. Close
4887.10
Open Price
4870.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
4839.90 (3)
| Key Financial Ratios of Pfizer (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 111.28 | 93.78 | 78.70 | 73.61 | 66.66 | |
| Diluted EPS (Rs.) | 111.28 | 93.78 | 78.70 | 73.61 | 66.66 | |
| Cash EPS (Rs.) | 133.85 | 109.39 | 93.18 | 87.37 | 79.33 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 742.18 | 658.22 | 586.49 | 528.72 | 472.90 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 742.18 | 658.22 | 586.49 | 528.72 | 472.90 | |
| Dividend / Share(Rs.) | 330.00 | 22.50 | 20.00 | 20.00 | 15.00 | |
| Revenue from Operations/Share (Rs.) | 470.31 | 454.97 | 430.28 | 429.78 | 439.86 | |
| PBDIT/Share (Rs.) | 165.37 | 160.13 | 134.33 | 98.42 | 113.44 | |
| PBIT/Share (Rs.) | 142.81 | 144.52 | 119.85 | 84.67 | 100.78 | |
| PBT/Share (Rs.) | 140.43 | 144.24 | 119.76 | 112.97 | 102.83 | |
| Net Profit/Share (Rs.) | 111.29 | 93.78 | 78.70 | 73.61 | 66.66 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 35.16 | 35.19 | 31.22 | 22.90 | 25.79 | |
| PBIT Margin (%) | 30.36 | 31.76 | 27.85 | 19.70 | 22.91 | |
| PBT Margin (%) | 29.86 | 31.70 | 27.83 | 26.28 | 23.37 | |
| Net Profit Margin (%) | 23.66 | 20.61 | 18.29 | 17.12 | 15.15 | |
| Return on Networth / Equity (%) | 14.99 | 14.24 | 13.41 | 13.92 | 14.09 | |
| Return on Capital Employed (%) | 18.49 | 21.69 | 20.04 | 15.61 | 13.67 | |
| Return on Assets (%) | 11.55 | 10.88 | 9.75 | 10.32 | 10.56 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 48.84 | 52.83 | 53.34 | 60.29 | 69.67 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 3.49 | 3.05 | 2.53 | 2.63 | 2.45 | |
| Quick Ratio (X) | 3.00 | 2.61 | 2.22 | 2.22 | 1.90 | |
| Inventory Turnover Ratio (X) | 5.00 | 5.38 | 6.63 | 6.11 | 5.58 | |
| Dividend Payout Ratio (NP) (%) | 24.37 | 25.70 | 30.58 | 24.52 | 22.56 | |
| Dividend Payout Ratio (CP) (%) | 20.26 | 22.04 | 25.83 | 20.66 | 18.96 | |
| Earnings Retention Ratio (%) | 75.63 | 74.30 | 69.42 | 75.48 | 77.44 | |
| Cash Earnings Retention Ratio (%) | 79.74 | 77.96 | 74.17 | 79.34 | 81.04 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 16,195.40 | 13,279.91 | 8,228.62 | 7,137.37 | 7,151.23 | |
| EV/Net Operating Revenue (X) | 7.53 | 6.38 | 4.18 | 3.63 | 3.55 | |
| EV/EBITDA (X) | 21.41 | 18.13 | 13.39 | 15.85 | 13.78 | |
| MarketCap/Net Operating Revenue (X) | 8.56 | 7.30 | 5.08 | 4.40 | 4.06 | |
| Retention Ratios (%) | 75.62 | 74.29 | 69.41 | 75.47 | 77.43 | |
| Price/BV (X) | 5.42 | 5.04 | 3.73 | 3.58 | 3.78 | |
| Price/Net Operating Revenue | 8.56 | 7.30 | 5.08 | 4.40 | 4.06 | |
| Earnings Yield | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 |
10.02.2026
Pfizer Standalone December 2025 Net Sales at Rs 645.03 crore, up 19.9% Y-o-Y
13.11.2025
Pfizer Standalone September 2025 Net Sales at Rs 642.34 crore, up 9.13% Y-o-Y
20.05.2025
Pfizer Standalone March 2025 Net Sales at Rs 591.91 crore, up 8.28% Y-o-Y
01.02.2025
Pfizer Standalone December 2024 Net Sales at Rs 537.99 crore, down 0.37% Y-o-Y
19.10.2016
05.08.2016
03.01.2014
10.01.2011
06.04.2026
06.04.2026
02.04.2026
02.04.2026
Lupin shares down 2% as arm to acquire 43.38% stake in Multicare Pharma
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth